Total Payments
$48,190
2024 Payments
$739.58
Companies
31
Transactions
192
Medicare Patients
6,247
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$35,255 (73.2%)
Food & Beverage$5,355 (11.1%)
Consulting$4,500 (9.3%)
Travel$2,953 (6.1%)
Education$126.99 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,255 | 19 | 73.2% |
| Food and Beverage | $5,355 | 146 | 11.1% |
| Consulting Fee | $4,500 | 1 | 9.3% |
| Travel and Lodging | $2,953 | 24 | 6.1% |
| Education | $126.99 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $29,865 | 55 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $14,072 | 28 | $0 (2018) |
| GlaxoSmithKline, LLC. | $1,018 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $350.03 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $321.40 | 5 | $0 (2023) |
| Relypsa, Inc. | $275.41 | 15 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $253.74 | 10 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $240.28 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $226.54 | 11 | $0 (2024) |
| Amgen Inc. | $185.63 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $739.58 | 20 | Ardelyx, Inc. ($175.97) |
| 2023 | $3,968 | 32 | AKEBIA THERAPEUTICS INC ($2,436) |
| 2022 | $7,679 | 15 | AKEBIA THERAPEUTICS INC ($7,328) |
| 2021 | $9,478 | 18 | AKEBIA THERAPEUTICS INC ($9,106) |
| 2020 | $184.01 | 8 | AKEBIA THERAPEUTICS INC ($58.62) |
| 2019 | $11,377 | 46 | AKEBIA THERAPEUTICS INC ($10,917) |
| 2018 | $14,417 | 43 | Keryx Biopharmaceuticals, Inc. ($14,072) |
| 2017 | $346.75 | 10 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($122.20) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Immunology | ||||||
| 08/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: NEPHROLOGY | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: CRITICAL CARE | ||||||
| 07/30/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Nephrology | ||||||
| 03/12/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEPHROLOGY | ||||||
| 03/06/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $120.91 | General |
| Category: NEPHROLOGY | ||||||
| 02/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/20/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiology | ||||||
| 02/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Nephrology | ||||||
| 01/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: NEPHROLOGY | ||||||
| 01/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $130.00 | General |
| 12/27/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Diabetes | ||||||
| 12/21/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2023 | Fresenius USA Marketing, Inc. | KORSUVA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: KORSUVA a Kappa opioid receptor agonist for pruritus companied with chronic kidney disease CKD-aP | ||||||
| 11/07/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: KRYSTEXXA | ||||||
| 10/31/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,517 | 2,681 | $766,620 | $261,250 |
| 2022 | 18 | 1,318 | 2,044 | $596,848 | $224,649 |
| 2021 | 19 | 1,595 | 2,552 | $577,885 | $288,275 |
| 2020 | 16 | 1,817 | 3,209 | $693,976 | $334,317 |
Total Patients
6,247
Total Services
10,486
Medicare Billing
$1.1M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 227 | 529 | $123,786 | $50,717 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 347 | 743 | $184,264 | $40,172 | 21.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 59 | 115 | $79,120 | $32,857 | 41.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 200 | 411 | $64,116 | $25,790 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 141 | 212 | $73,776 | $22,737 | 30.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 146 | 153 | $52,326 | $20,998 | 40.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 29 | 76 | $43,472 | $16,996 | 39.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 81 | 81 | $34,830 | $13,451 | 38.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 72 | $38,736 | $12,345 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 111 | $19,536 | $5,904 | 30.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 19 | $10,868 | $4,555 | 41.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 44 | $11,352 | $4,545 | 40.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 23 | 24 | $9,456 | $3,076 | 32.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $6,942 | $1,756 | 25.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 21 | 30 | $4,200 | $1,674 | 39.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Office | 2023 | 11 | 24 | $3,360 | $1,389 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,912 | $1,233 | 31.5% |
| G0420 | Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour | Office | 2023 | 12 | 12 | $2,568 | $1,055 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 354 | 617 | $157,248 | $56,344 | 35.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 72 | 150 | $107,530 | $43,134 | 40.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 181 | 353 | $72,436 | $28,926 | 39.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 110 | 113 | $44,765 | $17,904 | 40.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 158 | 293 | $42,022 | $16,453 | 39.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 79 | 98 | $35,346 | $13,324 | 37.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 77 | 77 | $34,138 | $11,544 | 33.8% |
About Dr. Rohit Pankhaniya, MD
Dr. Rohit Pankhaniya, MD is a Nephrology healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356398200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rohit Pankhaniya, MD has received a total of $48,190 in payments from pharmaceutical and medical device companies, with $739.58 received in 2024. These payments were reported across 192 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,255).
As a Medicare-enrolled provider, Pankhaniya has provided services to 6,247 Medicare beneficiaries, totaling 10,486 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Port Charlotte, FL
- Active Since 05/27/2006
- Last Updated 09/01/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1356398200
Products in Payments
- Auryxia (Drug) $32,962
- AURYXIA (Drug) $5,980
- JESDUVROQ (Drug) $975.00
- Kerendia (Drug) $321.40
- ACTHAR (Biological) $309.62
- Veltassa (Drug) $275.41
- KRYSTEXXA (Biological) $251.42
- FARXIGA (Drug) $249.71
- RAYALDEE (Drug) $173.14
- Renal - CRRT (Device) $139.89
- SAMSCA (Drug) $136.75
- UPTRAVI (Drug) $124.99
- TOLVAPTAN (Drug) $122.20
- XPHOZAH 30 MG (Drug) $120.91
- ENTRESTO (Drug) $109.32
- LOKELMA (Drug) $100.32
- JYNARQUE (Drug) $89.79
- Rayaldee (Drug) $80.60
- JARDIANCE (Drug) $64.51
- IBSRELA (Drug) $55.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Port Charlotte
Dr. Kianoosh Kaveh, Do, DO
Nephrology — Payments: $93,966
Nephrology $93,966
Dr. Nandheesha Hanumanthappa, Md, MD
Nephrology — Payments: $2,187
Nephrology $2,187
Lalita Thatte, Md, MD
Nephrology — Payments: $198.65
Nephrology $198.65
Ramachandran Rajaram, Md, MD
Nephrology — Payments: $44.52
Nephrology $44.52
Graciela Deboccardo, Md, MD
Nephrology
Nephrology
Dr. Dorothy Nemec, M.d, M.D
Nephrology
Nephrology